Analyst picks & changes

Magainin Pharmaceuticals Inc.

(MAGN)

David Stone of Cowen & Co. initiated coverage with a "strong buy" based on MAGN's

Read the full 194 word article

How to gain access

Continue reading with a
two-week free trial.